Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1998
11/10/1998US5834437 Wound healing agents
11/10/1998US5834436 Membrane-permeant second messengers
11/10/1998US5834260 Antiparasitic agents
11/10/1998US5834256 Novel retroviral packaging system, transfection in human cells
11/10/1998US5834248 Treatment and diagnosis of cardiovascular disease
11/10/1998US5834234 Nucleotide sequence coding; diagnosis of degenerative disorders
11/10/1998US5834192 Amino acid sequences, nucleotide sequenes and complements; identified from breast tumor libraries; diagnosing with hybridization complexes; host cells transfected with expression vectors; antisense molecules for treatment
11/10/1998US5834188 For inducing human osteogenic protein 1
11/10/1998US5834186 Regulatable RNA molecule
11/10/1998US5834044 Provides enhanced in vivo oxidative defense indices and prevents or attenuates exercise induced in vivo oxidative stress
11/10/1998US5834032 Compositions and methods for treating diabetes
11/10/1998US5834024 Controlled absorption diltiazem pharmaceutical formulation
11/10/1998US5834023 Diltiazem controlled release formulation
11/10/1998US5834019 Pharmaceutical formulation containing a hydrophobic active substance and an effervescent system
11/10/1998US5834016 Mixtures of (di-)hydroxycholecalciferol, lecithins, cholesterol or its organic acid or (poly)ethylene glycol derivatives and a lower alkyl alcohol; for treatment of psoriasis, good skin penetration
11/10/1998US5834014 Modifying minoxidil with alpha-hydroxy acid to make it more hydrophilic, encapsulating in a lipid vesicle of glycerol dilaurate; improved penetration for topical delivery
11/10/1998US5834012 Lipid complexed topoisomerase I inhibitors
11/10/1998US5834010 Triacetin as a penetration enhancer for transdermal delivery of a basic drug
11/10/1998US5834008 Composition and method for acceleration of wound and burn healing
11/10/1998US5834004 Enteral composition comprising dimethicone and a photosensitizer and a method of delivery
11/10/1998US5834002 Water insoluble gum base with water soluble bulk portion, flavors, colloidal bismuth salts of hydroxy carboxylic aicds, for treating helicobacter pylori infections, antiulcer agents
11/10/1998US5833996 Treatment of psoriasis using dead cells of Mycobacterium vaccae
11/10/1998US5833994 Use of the AH receptor and AH receptor ligands to treat or prevent cytopathicity of viral infection
11/10/1998US5833952 Stannous compound-containing composition for dentifrices, mouthwashes
11/10/1998US5833950 Particle size control, fluorocarbon propellant
11/10/1998CA2161697C Method and means for inhibiting posterior capsule opacification
11/10/1998CA2160082C Mixture having antitumor activities
11/10/1998CA2145682C 2-substituted adenosines with a-2 receptor affinity
11/10/1998CA2114877C Preparation of carbonic anhydrase inhibitors
11/10/1998CA2073005C Antimuscarinic bronchodilators
11/10/1998CA2006201C Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors
11/09/1998CA2237267A1 Synthesis of the sulfonylpyrimidine derivatives with anticancer activity
11/09/1998CA2237052A1 Substituted diaminocarboxylic acids
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/05/1998WO1998049560A1 Cadherin-11 as an indicator of viable pregnancy
11/05/1998WO1998049350A1 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
11/05/1998WO1998049349A1 ANTISENSE INHIBITION OF ras GENE WITH CHIMERIC AND ALTERNATING OLIGONUCLEOTIDES
11/05/1998WO1998049348A1 Oligonucleotides for enhanced bioavailability
11/05/1998WO1998049346A1 Enzymatic dna molecules
11/05/1998WO1998049315A2 Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold
11/05/1998WO1998049299A1 Leukemia associated genes
11/05/1998WO1998049292A2 Polypeptides associated with activator receptors and their biological applications
11/05/1998WO1998049291A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways
11/05/1998WO1998049290A2 Syndecan interacting proteins and the use thereof
11/05/1998WO1998049288A1 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection
11/05/1998WO1998049191A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
11/05/1998WO1998049177A1 Anti-viral pyrimidine nucleoside analogues
11/05/1998WO1998049173A1 Vanadium complexes and derivatives thereof and methods related thereto
11/05/1998WO1998049170A1 Spiro-azacyclic derivatives and their use as therapeutic agents
11/05/1998WO1998049169A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/05/1998WO1998049168A1 Reverse-turn mimetics and methods relating thereto
11/05/1998WO1998049166A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
11/05/1998WO1998049165A1 CYTOTOXIC COMPOUNDS: DERIVATIVES OF THE PYRIDO[2,3,4-kl] ACRIDINE RING SYSTEM
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998049161A1 Antithrombotic agents
11/05/1998WO1998049160A1 Antithrombotic agents
11/05/1998WO1998049157A1 Farnesyltransferase inhibiting quinazolinones
11/05/1998WO1998049155A1 Cell differentiation inducing amide derivatives, their production and use
11/05/1998WO1998049154A1 Alpha-tocopherol 4-aminobenzoic acid ester compounds and method for preparing the same
11/05/1998WO1998049153A1 Preparation of isoflavones from legumes
11/05/1998WO1998049152A1 Protease inhibitors
11/05/1998WO1998049146A2 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
11/05/1998WO1998049145A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/05/1998WO1998049138A2 Vitamin d3 analogs with bis c-20 side chains
11/05/1998WO1998049134A1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate
11/05/1998WO1998049131A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
11/05/1998WO1998049129A1 Conjugated linolenic acid-based synthetic triglycerides
11/05/1998WO1998048845A1 Method of demarcating tissue
11/05/1998WO1998048839A1 Topical nasal antiinflammatory compositions
11/05/1998WO1998048838A1 Compounds
11/05/1998WO1998048822A1 Improved methods for processing activated protein c
11/05/1998WO1998048819A1 Condensation polymer composition for preventing pregnancy
11/05/1998WO1998048818A1 Activated protein c formulations
11/05/1998WO1998048817A1 Use of sialyl galactosides and related compounds as anti-angiogenic agents
11/05/1998WO1998048815A1 Use of zinc hyaluronate against peptic ulcer
11/05/1998WO1998048814A1 Pourable alginate compositions
11/05/1998WO1998048813A1 Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells
11/05/1998WO1998048812A1 Use of anabolic steroid derivatives in the treatment of chronic heart failure
11/05/1998WO1998048810A1 Composition and methods using an eutomer
11/05/1998WO1998048809A1 Use of immunomodulating agents
11/05/1998WO1998048808A1 Herbicide anti-apicomplexa protozoan parasite agents
11/05/1998WO1998048807A1 Hyaluronate synthesis inhibitors
11/05/1998WO1998048806A1 Indene compounds having activity as serms
11/05/1998WO1998048805A1 Pharmaceutical composition for supressing type 2 helper t cell immune response
11/05/1998WO1998048804A1 Antithrombotic agents
11/05/1998WO1998048803A1 Eyedrops
11/05/1998WO1998048802A1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
11/05/1998WO1998048800A1 Antithrombotic agents
11/05/1998WO1998048799A1 Protease inhibitors
11/05/1998WO1998048798A1 Antithrombotic agents
11/05/1998WO1998048797A1 Antithrombotic agents
11/05/1998WO1998048796A1 Use of melatonin for preparing medicaments for treating circadian rhythm phase disorders
11/05/1998WO1998048795A1 Therapeutic treatment for skin disorders
11/05/1998WO1998048794A1 Antithrombotic agents
11/05/1998WO1998048790A1 Use of genistein and related compounds to treat certain sex hormone related conditions
11/05/1998WO1998048789A1 Pharmaceutical compositions of arglabin and arglabin derivatives
11/05/1998WO1998048788A1 Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
11/05/1998WO1998048786A1 AMINOTETRALINS AS 5-HT1Dα AGONISTS
11/05/1998WO1998048785A2 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998WO1998048784A2 Method and composition for modulating amyloidosis
1 ... 6584 6585 6586 6587 6588 6589 6590 6591 6592 6593 6594 6595 6596 6597 6598 6599 6600 6601 6602 6603 6604 ... 7860